Nearly 30,000 diabetes who rely on insulin use the Sugarmate app. [Image courtesy of Sugarmate]
Tandem Diabetes Care (NSDQ:TNDM) said today that it has purchased Sugarmate — as mobile app that helps people better manage their diabetes.
Financial terms of the deal were not disclosed. Nearly 30,000 people relying on insulin pumps or multiple daily injections presently use the Sugarmate app.
Sugarmate cofounder Josh Juster will join Tandem as a VP and will continue to lead Sugarmate as a wholly-owned subsidiary of the insulin pump maker.
Sugarmate’s creators designed it to help people visualize their diabetes therapy data in an innovative way. They can log glucose data and health and nutrition information and receive notifications and alerts that can also go to designated family and caregivers.
“Our acquisition of Sugarmate represents an exciting addition to our digital offerings, and supports Tandem’s strategic vision to expand our ecosystem of diabetes-related products and services,” Tandem Diabetes Care CEO John Sheridan said in a news release.
Tandem Diabetes Care officials do not intend for Sugarmate to replace their t:connect mobile app, which is expected to launch for t:slim X2 pump users this summer.